Worldwide Enterprise Machines Corp. is exploring a possible sale of its IBM Watson Well being enterprise, in response to folks accustomed to the matter, because the expertise large’s new chief government strikes to streamline the corporate and grow to be extra aggressive in cloud computing.
IBM is learning options for the unit that would embody a sale to a private-equity agency or trade participant or a merger with a blank-check firm, the folks mentioned. The unit, which employs synthetic intelligence to assist hospitals, insurers and drugmakers handle their knowledge, has roughly $1 billion in annual income and isn’t at present worthwhile, the folks mentioned.
Its manufacturers embody Merge Healthcare, which analyzes mammograms and MRIs; Phytel, which assists with affected person communications; and Truven Well being Analytics, which analyzes advanced healthcare knowledge.
It isn’t clear how a lot the enterprise may fetch in a sale, and there will not be one.
IBM, with a market worth of $108 billion, has been left behind as cloud-computing rivals Microsoft Corp. and Amazon.com Inc. soar to valuations greater than 10 occasions better. The Armonk, N.Y., firm has mentioned it’s targeted on boosting its hybrid-cloud operations whereas exiting some unrelated companies.